190 related articles for article (PubMed ID: 28929029)
21. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
[TBL] [Abstract][Full Text] [Related]
22. Association of MIR146A rs2910164 variation with a predisposition to sporadic breast cancer in a Pakistani cohort.
Ahmad M; Ahmad S; Rahman B; Haq TU; Jalil F; Shah AA
Ann Hum Genet; 2019 Sep; 83(5):325-330. PubMed ID: 30963551
[TBL] [Abstract][Full Text] [Related]
23. Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study.
Lin S; Zheng Y; Wang M; Zhou L; Zhu Y; Deng Y; Wu Y; Zhang D; Li N; Kang H; Dai Z
Mol Biol Rep; 2022 Mar; 49(3):2255-2263. PubMed ID: 35079936
[TBL] [Abstract][Full Text] [Related]
24. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
25. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM
Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343
[TBL] [Abstract][Full Text] [Related]
26. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Dimberg J; Hugander A; Löfgren S; Wågsäter D
Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
[TBL] [Abstract][Full Text] [Related]
28. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
29. Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism.
Jafarzadeh A; Fooladseresht H; Nemati M; Assadollahi Z; Sheikhi A; Ghaderi A
Cancer Biomark; 2016 Mar; 16(4):545-54. PubMed ID: 27002757
[TBL] [Abstract][Full Text] [Related]
30. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
31. CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma.
Qin LF; Qin JM; Zhang JQ; Lv XP; Huang LY; Wang JJ
Future Oncol; 2018 Jun; 14(13):1261-1271. PubMed ID: 29741398
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
[TBL] [Abstract][Full Text] [Related]
33. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
34. Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
Ramezani S; Sharafshah A; Mirzanejad L; Hadavi M
Gene; 2019 Sep; 712():143954. PubMed ID: 31288058
[TBL] [Abstract][Full Text] [Related]
35. Association of a potential functional mir-520f rs75598818 G>A polymorphism with breast cancer.
Meshkat M; Mesrian Tanha H; Ghaedi K; Meshkat M
J Genet; 2018 Dec; 97(5):1307-1313. PubMed ID: 30555079
[TBL] [Abstract][Full Text] [Related]
36. Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.
Bodelon C; Malone KE; Johnson LG; Malkki M; Petersdorf EW; McKnight B; Madeleine MM
Int J Mol Epidemiol Genet; 2013; 4(4):218-27. PubMed ID: 24319537
[TBL] [Abstract][Full Text] [Related]
37. Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer.
Francelino AL; Pereira ÉR; Pinheiro LCL; Soares AC; Mendonça AC; Fuganti PE; Frantine-Silva W; de Oliveira KB; Serpeloni JM; Guembarovski RL
Pathol Res Pract; 2023 Oct; 250():154806. PubMed ID: 37738928
[TBL] [Abstract][Full Text] [Related]
38. Association of CDH1 and TERT Single-Nucleotide Polymorphisms with Susceptibility to Familial Breast Cancer Risk.
Bagherpour M; Gharibzad K; Rassi H
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):239-244. PubMed ID: 30543312
[TBL] [Abstract][Full Text] [Related]
39. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
40. Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients.
Dąbrowska E; Przylipiak A; Zajkowska M; Piskor BM; Sidorkiewicz I; Szmitkowski M; Lawicki S
Anticancer Res; 2020 Jun; 40(6):3221-3229. PubMed ID: 32487616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
